IRIS Accounts Production v25.1.3.33 10118056 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101180562023-12-31101180562024-12-31101180562024-01-012024-12-31101180562022-12-31101180562023-01-012023-12-31101180562023-12-3110118056ns15:EnglandWales2024-01-012024-12-3110118056ns14:PoundSterling2024-01-012024-12-3110118056ns10:Director12024-01-012024-12-3110118056ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110118056ns10:SmallEntities2024-01-012024-12-3110118056ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3110118056ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110118056ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110118056ns10:FullAccounts2024-01-012024-12-3110118056ns10:OrdinaryShareClass12024-01-012024-12-3110118056ns10:Director22024-01-012024-12-3110118056ns10:Director32024-01-012024-12-3110118056ns10:Director42024-01-012024-12-3110118056ns10:CompanySecretary12024-01-012024-12-3110118056ns10:RegisteredOffice2024-01-012024-12-3110118056ns5:CurrentFinancialInstruments2024-12-3110118056ns5:CurrentFinancialInstruments2023-12-3110118056ns5:Non-currentFinancialInstruments2024-12-3110118056ns5:Non-currentFinancialInstruments2023-12-3110118056ns5:ShareCapital2024-12-3110118056ns5:ShareCapital2023-12-3110118056ns5:SharePremium2024-12-3110118056ns5:SharePremium2023-12-3110118056ns5:RetainedEarningsAccumulatedLosses2024-12-3110118056ns5:RetainedEarningsAccumulatedLosses2023-12-3110118056ns5:ComputerEquipment2023-12-3110118056ns5:ComputerEquipment2024-01-012024-12-3110118056ns5:ComputerEquipment2024-12-3110118056ns5:ComputerEquipment2023-12-3110118056ns5:CostValuation2023-12-3110118056ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110118056ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3110118056ns10:OrdinaryShareClass12024-12-3110118056ns5:RetainedEarningsAccumulatedLosses2023-12-3110118056ns5:SharePremium2023-12-3110118056ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-31
REGISTERED NUMBER: 10118056 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

MEDESK LIMITED

MEDESK LIMITED (REGISTERED NUMBER: 10118056)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEDESK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: Ms E Dyson
Mr V Kovalskii
Mr A Sokolov
Mr S Zhiltsov





SECRETARY: Mr I I Livant





REGISTERED OFFICE: 3rd Floor 207 Regent Street,
London
W1B 3HH





REGISTERED NUMBER: 10118056 (England and Wales)





ACCOUNTANTS: Fusion Accountancy Limited
Marlborough House
298 Regents Park Road
London
N3 2SZ

MEDESK LIMITED (REGISTERED NUMBER: 10118056)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.12.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 794 1,156
Investments 5 2,090 2,090
2,884 3,246

CURRENT ASSETS
Debtors 6 643,355 993,515
Cash at bank 19,445 95,241
662,800 1,088,756
CREDITORS
Amounts falling due within one year 7 20,534 2,833
NET CURRENT ASSETS 642,266 1,085,923
TOTAL ASSETS LESS CURRENT
LIABILITIES

645,150

1,089,169

CREDITORS
Amounts falling due after more than one
year

8

493,513

623,730
NET ASSETS 151,637 465,439

CAPITAL AND RESERVES
Called up share capital 9 193 193
Share premium 10 2,455,501 2,455,501
Retained earnings 10 (2,304,057 ) (1,990,255 )
SHAREHOLDERS' FUNDS 151,637 465,439

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDESK LIMITED (REGISTERED NUMBER: 10118056)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 June 2025 and were signed on its behalf by:





Mr V Kovalskii - Director


MEDESK LIMITED (REGISTERED NUMBER: 10118056)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Medesk Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer Equipment 33% on cost

Going concern
The directors have formed a judgement at the time of approving the Annual Financial Statements, that there is a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason the directors have adopted the going concern basis in preparing the accounts.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2024
and 31 December 2024 5,578
DEPRECIATION
At 1 January 2024 4,422
Charge for year 362
At 31 December 2024 4,784
NET BOOK VALUE
At 31 December 2024 794
At 31 December 2023 1,156

MEDESK LIMITED (REGISTERED NUMBER: 10118056)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 January 2024
and 31 December 2024 2,090
NET BOOK VALUE
At 31 December 2024 2,090
At 31 December 2023 2,090

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Limited Liability Company: Medesk LLC
Registered office: 121087, Moscow City, Zarechnaya Str., House No. 9

Nature of business: Software Development
Ownership: 100%
Total nominal aggregate value RUB10,000 / £74

The company's financial position as at 31st December 2024 was:
Aggregate capital and reserves - (RUB 75,592,000) / (£556,621)
Profit for the year - (RUB 1,139,000) / (£8,387)
(Average Exchange Rate: £1 = RUB 135.8)

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors - 218
Other debtors 643,355 993,297
643,355 993,515

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 300 300
Corporation tax 17,722 -
Net wages 254 275
Director's current account 2,258 2,258
20,534 2,833

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.12.24 31.12.23
£    £   
Other creditors 493,513 623,730

MEDESK LIMITED (REGISTERED NUMBER: 10118056)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
19,289 Ordinary 0.01 193 193

10. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 January 2024 (1,990,255 ) 2,455,501 465,246
Deficit for the year (313,802 ) (313,802 )
At 31 December 2024 (2,304,057 ) 2,455,501 151,444

11. RELATED PARTY DISCLOSURES

At the year end, the company owed the director V Kovalskii of £2,258 (2023: £2,258).

Included under debtors are loans given to:
Medesk LLC of £643,355 (2023: £993,297).

12. TAXATION

The company has carried forward losses of £2,166,195 (2023: £1,861,156) which it can use against future taxable profits.